title: Proteasome inhibitor bortezomib-induced apoptosis in natural killer (NK)-cell leukemia and lymphoma: an in vitro and in vivo preclinical evaluation.
authors.forename: Lijun
authors.initials: L
authors.lastname: Shen
authors.forename: Wing-Yan
authors.initials: WY
authors.lastname: Au
authors.forename: Tianhuan
authors.initials: T
authors.lastname: Guo
authors.forename: Kai-Yau
authors.initials: KY
authors.lastname: Wong
authors.forename: Michelle L
authors.initials: ML
authors.lastname: Wong
authors.forename: Junjiro
authors.initials: J
authors.lastname: Tsuchiyama
authors.forename: Po-Wing
authors.initials: PW
authors.lastname: Yuen
authors.forename: Yok-Lam
authors.initials: YL
authors.lastname: Kwong
authors.forename: Raymond H
authors.initials: RH
authors.lastname: Liang
authors.forename: Gopesh
authors.initials: G
authors.lastname: Srivastava
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D045744:Cell Line, Tumor; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects / Q000473:pathology*; D015458:Leukemia, T-Cell / Q000188:drug therapy* / Q000473:pathology; D016399:Lymphoma, T-Cell / Q000188:drug therapy* / Q000473:pathology; D011480:Protease Inhibitors / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use*; D014407:Tumor Cells, Cultured
chemical_list: D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib